Skip to main content

Table 4 Subgroup analyses in the intention-to-treat group, to be presented as forest plots

From: Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan

Subgroup

Number (%)

Estimated mean differencea

95% Confidence Interval

P value

Intervention (GKT137831) group (n = xxx)

Placebo group (n = xxx)

Sex

 Male

     

 Female

     

Age

 < median

     

 ≥ median

     

Diabetes mellitus duration

 < median

     

 ≥ median

     

BMI

 < median

     

 ≥ median

     

HbA1c

 < median

     

 ≥ median

     
  1. BMI body mass index, HbA1c glycated haemoglobin
  2. a In the intervention group compared to placebo
Back to article page

Trials

ISSN: 1745-6215